FMO5 and type 2 diabetes mellitus: In summary, we have observed that reported inhibitors of NADPH oxidase enzymes do not alter agonist-evoked, endothelium-dependent vasodilatory responses in skeletal muscle resistance arteries from either healthy or T2D adult male rats.